Zydus Lifesciences gets USFDA approval for angina, high blood pressure drug

Zydus Lifesciences has secured USFDA approval to market Diltiazem Hydrochloride tablets, used for treating angina and high blood pressure, in strengths of 30 mg, 60 mg, 90 mg, and 120 mg. The medication, a calcium-channel blocker, relaxes blood vessels, easing the heart's workload and improving blood flow.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/4CdspvA
via IFTTT